Neuroprotective Effects of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Gliflozins) on Diabetes-Induced Neurodegeneration and Neurotoxicity: A Graphical Review.
鈉-葡萄糖共轉運蛋白-2 (SGLT2) 抑制劑 (Gliflozins) 對糖尿病引起的神經退行性變和神經毒性的神經保護作用:圖形回顧。
Int J Prev Med 2024-09-06
Molecular and neural roles of sodium-glucose cotransporter 2 inhibitors in alleviating neurocognitive impairment in diabetic mice.
鈉葡萄糖共同轉運蛋白2抑制劑在緩解糖尿病小鼠神經認知障礙中的分子和神經作用。
Psychopharmacology (Berl) 2023-04-27
Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways.
老年人糖尿病-阿茲海默症關聯:SGLT2 抑制劑作為疾病途徑的有前途的調節劑。
Ageing Res Rev 2023-09-17
Risk of Dementia in Patients with Diabetes Using Sodium-Glucose Transporter 2 Inhibitors (SGLT2i): A Systematic Review, Meta-Analysis, and Meta-Regression.
糖尿病患者使用鈉葡萄糖轉運蛋白2抑制劑(SGLT2i)與癡呆症風險:系統性回顧、荟萃分析和荟萃回歸。
Diabetes Ther 2024-03-18
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis.
SGLT2抑制劑在糖尿病患者中對失智症發病和認知功能的潛在作用:系統性回顧和荟萃分析。
Front Neuroendocrinol 2024-02-24
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects.
糖尿病藥物中的胰高血糖素樣肽-1受體激動劑和鈉-葡萄糖共轉運蛋白2抑制劑對心臟衰竭和認知障礙的保護作用:潛在的保護效應機制。
Front Pharmacol 2024-07-01
Microglia Involvement into Acute and Chronic Brain Damage in Diabetic Rats: Impact of GLP-1RA and SGLT-2i.
微膠質細胞在糖尿病大鼠急性和慢性腦損傷中的參與:GLP-1RA 和 SGLT-2i 的影響。
Front Biosci (Landmark Ed) 2024-07-31
SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system.
SGLT2 抑制劑:通過對神經系統的多方面影響治療認知障礙的新療法。
Transl Neurodegener 2024-08-09
SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes.
SGLT2 抑制劑使用與 2 型糖尿病患者罹患癡呆症和帕金森病的風險。
Neurology 2024-09-18